Advertisement
Zynex, Inc.

Zynex, Inc. Fundamental Analysis

ZYXINASDAQ
HealthcareMedical - Distribution
$0.13
$0.07(140.38%)
U.S. Market opens in 7h 50m
Advertisement

Zynex, Inc. Fundamental Analysis

Zynex, Inc. (ZYXI) shows moderate financial fundamentals with a PE ratio of -0.05, profit margin of -1.18%, and ROE of 11.38%. The company generates $0.1B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position349.91%
PEG Ratio0.00

Areas of Concern

Operating Margin-1.08%
Current Ratio0.47
We analyze ZYXI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -48.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-48.1/100

We analyze ZYXI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ZYXI struggles to generate sufficient returns from assets.

ROA > 10%
-1.62%

Valuation Score

Excellent

ZYXI trades at attractive valuation levels.

PE < 25
-0.05
PEG Ratio < 2
0.00

Growth Score

Weak

ZYXI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ZYXI shows balanced financial health with some risks.

Debt/Equity < 1
-1.73
Current Ratio > 1
0.47

Profitability Score

Weak

ZYXI struggles to sustain strong margins.

ROE > 15%
11.38%
Net Margin ≥ 15%
-1.18%
Positive Free Cash Flow
No

Key Financial Metrics

Is ZYXI Expensive or Cheap?

P/E Ratio

ZYXI trades at -0.05 times earnings. This suggests potential undervaluation.

-0.05

PEG Ratio

When adjusting for growth, ZYXI's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values Zynex, Inc. at -0.09 times its book value. This may indicate undervaluation.

-0.09

EV/EBITDA

Enterprise value stands at 0.84 times EBITDA. This is generally considered low.

0.84

How Well Does ZYXI Make Money?

Net Profit Margin

For every $100 in sales, Zynex, Inc. keeps $-1.18 as profit after all expenses.

-1.18%

Operating Margin

Core operations generate -1.08 in profit for every $100 in revenue, before interest and taxes.

-1.08%

ROE

Management delivers $11.38 in profit for every $100 of shareholder equity.

11.38%

ROA

Zynex, Inc. generates $-1.62 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.62%

Following the Money - Real Cash Generation

Operating Cash Flow

Zynex, Inc. generates limited operating cash flow of $-23.07M, signaling weaker underlying cash strength.

$-23.07M

Free Cash Flow

Zynex, Inc. generates weak or negative free cash flow of $-23.28M, restricting financial flexibility.

$-23.28M

FCF Per Share

Each share generates $-0.77 in free cash annually.

$-0.77

FCF Yield

ZYXI converts -6.11% of its market value into free cash.

-6.11%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.05

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.09

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.06

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.73

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.47

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

11.38

vs 25 benchmark

ROA

Return on assets percentage

-1.62

vs 25 benchmark

ROCE

Return on capital employed

2.009

vs 25 benchmark

How ZYXI Stacks Against Its Sector Peers

MetricZYXI ValueSector AveragePerformance
P/E Ratio-0.0529.45 Better (Cheaper)
ROE1137.87%417.00% Excellent
Net Margin-117.86%-11442.00% (disorted) Weak
Debt/Equity-1.730.78 Strong (Low Leverage)
Current Ratio0.475.09 Weak Liquidity
ROA-161.83%-74.00% (disorted) Weak

ZYXI outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Zynex, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ